Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung and Pleural Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06318286
What this trial is testing

Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Hyogo Medical University 25
Early research (Phase 1)Study completedNCT00535951
What this trial is testing

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Who this might be right for
Carcinoma, Non-Small-Cell LungMesothelioma
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Looking for participantsNCT05543330
What this trial is testing

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

Who this might be right for
Malignant Pleural EffusionsNSCLC Stage IV
Wuhan YZY Biopharma Co., Ltd. 116
Not applicableStudy completedNCT02300883
What this trial is testing

Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients

Who this might be right for
Malignant Mesothelioma
Armando Santoro, MD 100
Not applicableEnded earlyNCT01551082
What this trial is testing

Outpatient Chest Tube Management Following Thoracic Resection Improves Patient Length of Stay and Satisfaction Without Compromising Outcomes

Who this might be right for
Lung CancerPneumothoraxSubcutaneous Emphysema
Alliance of Cardiothoracic and Vascular Surgeons 12
Not applicableStudy completedNCT02603315
What this trial is testing

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Who this might be right for
Malignant Pleural Mesotheliomas
Ain Shams University 50
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT00799240
What this trial is testing

MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
University of Kansas 27
Testing effectiveness (Phase 2)UnknownNCT05598268
What this trial is testing

T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorLung CancerLiver Cancer+2 more
ImmVira Pharma Co. Ltd 74
Testing effectiveness (Phase 2)Study completedNCT03654833
What this trial is testing

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University of Leicester 186
Testing effectiveness (Phase 2)Study completedNCT01358084
What this trial is testing

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

Who this might be right for
Advanced Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 137
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Testing effectiveness (Phase 2)Study completedNCT05660616
What this trial is testing

Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 40
Early research (Phase 1)Looking for participantsNCT07192900
What this trial is testing

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
David Bartlett, MD 10
Early research (Phase 1)UnknownNCT02580747
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Who this might be right for
Malignant MesotheliomaPancreatic CancerOvarian Tumor+3 more
Chinese PLA General Hospital 20
Early research (Phase 1)Study completedNCT01355965
What this trial is testing

Autologous Redirected RNA Meso-CIR T Cells

Who this might be right for
Malignant Pleural Mesothelioma
University of Pennsylvania 18
Not applicableLooking for participantsNCT07403630
What this trial is testing

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Who this might be right for
Acute LeukemiaMultiple MyelomaSquamous Cell Carcinoma+9 more
Azienda Ospedaliero-Universitaria di Parma 300
Not applicableWithdrawnNCT00581503
What this trial is testing

Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

Who this might be right for
Lung CancerPleural CancerProstate Cancer
University of California, Irvine
Testing effectiveness (Phase 2)Looking for participantsNCT05765084
What this trial is testing

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 15
Next Page